Print Page     Close Window     

SEC Filings

BIOTIME INC filed this Form 10-K/A on 04/02/2018
Entire Document




Item 15. Exhibits, Financial Statement Schedules


(a-1) Financial Statements.


The following financial statements of BioTime are filed in this Report:


Consolidated Balance Sheets

Consolidated Statements of Operations

Consolidated Statements of Comprehensive Loss

Consolidated Statements of Changes in Shareholders’ Equity

Consolidated Statements of Cash Flows


Notes to Consolidated Financial Statements


(a-2) Financial Statement Schedules


Audited financial statements of Asterias are filed as Exhibit 99.1


(a-3) Exhibits.




3.1   Restated Articles of Incorporation (1)
3.2   By-Laws, As Amended (2)
4.1   Specimen of Common Share Certificate (3)
4.2   Form of Warrant Issued June 2013 (4)
4.3   Warrant Agreement, dated as of October 1, 2013, as amended September 19, 2014, between BioTime, Inc. and American Stock Transfer & Trust Company, LLC as Warrant Agent for the benefit of Asterias Biotherapeutics, Inc. (5)
4.4   Warrant Issued October 1, 2013 to Asterias Biotherapeutics, Inc. (included in Exhibit 4.7) (5)
10.1   2002 Stock Option Plan, as amended (6)
10.2   Employment Agreement, dated October 10, 2007, between BioTime, Inc. and Michael D. West. (7)
10.3   Commercial License and Option Agreement between BioTime and Wisconsin Alumni Research Foundation (8)
10.4   License Agreement, dated July 10, 2008, between Embryome Sciences, Inc. and Advanced Cell Technology, Inc. (9)
10.5   First Amendment of Commercial License and Option Agreement, dated March 11, 2009, between BioTime and Wisconsin Alumni Research Foundation (10)
10.6   OrthoCyte Corporation 2010 Stock Option Plan; Form of OrthoCyte Corporation Stock Option Agreement (11)
10.7   BioTime Asia, Limited 2010 Stock Option Plan; Form of BioTime Asia Limited Stock Option Agreement (11)
10.8   License Agreement between BioTime, Inc. and Cornell University (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) (12)
10.9   LifeMap Sciences, Inc. 2011 Stock Option Plan; and Form of LifeMap Sciences, Inc. Stock Option Agreement (13)



© Copyright BioTime, Inc.